Quantum Genomics (France) Analysis
| ALQGC Stock | EUR 0.07 0 1.77% |
Quantum Genomics SA is overvalued with Real Value of 0.0606 and Hype Value of 0.0721. The main objective of Quantum Genomics stock analysis is to determine its intrinsic value, which is an estimate of what Quantum Genomics SA is worth, separate from its market price. There are two main types of Quantum Genomics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Quantum Genomics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Quantum Genomics' stock to identify patterns and trends that may indicate its future price movements.
The Quantum Genomics stock is traded in France on Euronext Paris, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in France. Quantum Genomics is usually not traded on Christmas Day, New Year 's Day, Easter Monday, International Workers ' Day, Victory in Europe Day, Assumption of Mary. Quantum Stock trading window is adjusted to Europe/Paris timezone.
Quantum |
Quantum Stock Analysis Notes
The company has price-to-book (P/B) ratio of 0.32. Some equities with similar Price to Book (P/B) outperform the market in the long run. Quantum Genomics recorded a loss per share of 0.73. The entity had not issued any dividends in recent years. The firm had 1:18 split on the 13th of December 2013. Quantum Genomics Socit Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It is also developing QGC011 that is in pre-clinical phase to treat hypertension with combination therapy and QGC006 to optimize the treatment of hypertension with a monotherapy drug. QUANTUM GENOMICS operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 13 people. For more info on Quantum Genomics SA please contact the company at 33 1 85 34 77 70 or go to https://www.quantum-genomics.com.Quantum Genomics Investment Alerts
| Quantum Genomics generated a negative expected return over the last 90 days | |
| Quantum Genomics has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 116.21 K. Net Loss for the year was (17.36 M) with loss before overhead, payroll, taxes, and interest of (12.47 M). | |
| Quantum Genomics SA has accumulated about 5.01 M in cash with (17.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Quantum Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Quantum Genomics's market, we take the total number of its shares issued and multiply it by Quantum Genomics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Quantum Genomics technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices.Quantum Genomics Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Quantum Genomics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Quantum Genomics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Quantum Genomics Outstanding Bonds
Quantum Genomics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Quantum Genomics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Quantum bonds can be classified according to their maturity, which is the date when Quantum Genomics SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
About Quantum Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Quantum Genomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Quantum shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Quantum Genomics. By using and applying Quantum Stock analysis, traders can create a robust methodology for identifying Quantum entry and exit points for their positions.
Quantum Genomics Socit Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It is also developing QGC011 that is in pre-clinical phase to treat hypertension with combination therapy and QGC006 to optimize the treatment of hypertension with a monotherapy drug. QUANTUM GENOMICS operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 13 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Quantum Genomics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Additional Tools for Quantum Stock Analysis
When running Quantum Genomics' price analysis, check to measure Quantum Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quantum Genomics is operating at the current time. Most of Quantum Genomics' value examination focuses on studying past and present price action to predict the probability of Quantum Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quantum Genomics' price. Additionally, you may evaluate how the addition of Quantum Genomics to your portfolios can decrease your overall portfolio volatility.